AI drug discovery company Isomorphic Labs, a Google DeepMind spin-out, raised $2.1 billion last week, which saw participation from the UK’s Sovereign AI Fund
Alphabet's majority ownership raises questions about where the London-based company fits wit...
Want to read this article? Subscribe to TFN Prime at super early discounted price
In Europe’s competitive startup landscape, one challenge remains: transforming technological ideas into scalable business models often requires early-stage…